Charles Schwab Investment Management Inc Eargo, Inc. Transaction History

Charles Schwab Investment Management Inc

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.75 - $5.6 $67,790 - $506,167	-90,387 Reduced 49.8%	91,113 $69,000
Q1 2022 May 13, 2022	SELL	$3.3 - $7.28 $9,797 - $21,614	-2,969 Reduced 1.61%	181,500 $961,000
Q4 2021 Feb 11, 2022	BUY	$4.6 - $10.21 $199,202 - $442,144	43,305 Added 30.68%	184,469 $941,000
Q3 2021 Nov 16, 2021	BUY	$6.59 - $38.71 $330,284 - $1.94 Million	50,119 Added 55.05%	141,164 $951,000
Q2 2021 Aug 16, 2021	BUY	$32.1 - $57.78 $835,081 - $1.5 Million	26,015 Added 40.0%	91,045 $3.63 Million
Q1 2021 May 17, 2021	BUY	$42.5 - $75.37 $71,187 - $126,244	1,675 Added 2.64%	65,030 $3.25 Million
Q4 2020 Feb 16, 2021	BUY	$33.49 - $57.94 $2.12 Million - $3.67 Million	63,355 New	63,355 $2.84 Million

33.4K

Ticker EAR
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 39,411,000
Market Cap $2.78B
Description
Eargo, Inc., a medical device company, engages in enhancing the quality of life of people with hearing loss in the United States. The company markets and sells hearing aids. It sells its products direct-to-consumer and through omni-channel. The company was formerly known as Aria Innovations, Inc. and changed its name to Eargo, Inc. in November 2...

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

Stay updated on Charles Schwab Investment Management Inc with notifications on news.